It was also found that YTHDF2 promotes the decay of UBXN1 mRNA through recognition of METTL3-mediated m6A modifications, thereby activating NF-κB and promoting the malignant progression of glioma (Chai et al., 2021). This evidence concerns the gene METTL3 and central nervous system cancer.